Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | Emerging Therapies of Multiple Sclerosis | Jeffrey Bennett, MD, PhD | NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art | |
2 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
3 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
4 | Neuro-Ophthalmic Consequences of Immune Therapy (PDF) | Lynn K. Gordon | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends | |
5 | Neuro-Ophthalmic Consequences of Immune Therapy (Slides) | Lynn K. Gordon | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends | |
6 | Neuro-Ophthalmic Consequences of Immune Therapy (Video) | Lynn K. Gordon | NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends |